The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients.
The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, current regulatory initiatives and the high cost of the therapy are affecting market growth.
The global stem cell market is estimated to be $88.3 B by 2014 and projected to grow 14.8 % from 2009 to 2014. The US currently holds a 60% share of the global stem cell market and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. (HWM and MarketsandMarkets)